Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Equity Average (2018 - 2025)

Historic Equity Average for Neuronetics (STIM) over the last 8 years, with Q3 2025 value amounting to $31.4 million.

  • Neuronetics' Equity Average rose 11853.86% to $31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.4 million, marking a year-over-year increase of 11853.86%. This contributed to the annual value of $33.0 million for FY2024, which is 2768.33% down from last year.
  • According to the latest figures from Q3 2025, Neuronetics' Equity Average is $31.4 million, which was up 11853.86% from $35.5 million recorded in Q2 2025.
  • Neuronetics' Equity Average's 5-year high stood at $99.6 million during Q2 2021, with a 5-year trough of $14.4 million in Q3 2024.
  • Moreover, its 5-year median value for Equity Average was $46.9 million (2023), whereas its average is $52.3 million.
  • Its Equity Average has fluctuated over the past 5 years, first surged by 23273.11% in 2021, then plummeted by 6551.46% in 2024.
  • Neuronetics' Equity Average (Quarter) stood at $88.1 million in 2021, then plummeted by 31.89% to $60.0 million in 2022, then crashed by 39.92% to $36.1 million in 2023, then crashed by 42.91% to $20.6 million in 2024, then skyrocketed by 52.66% to $31.4 million in 2025.
  • Its Equity Average was $31.4 million in Q3 2025, compared to $35.5 million in Q2 2025 and $35.7 million in Q1 2025.